Treatment with LT4 is associated with suppression of TSH and elevation of T3, which may exacerbate symptoms of peripheral thyrotoxicosis in patients with MCT8 deficiency [28]. This evidence concerns the gene SLC16A2 and hyperinsulinemic hypoglycemia, familial, 4.